Immunotherapy of Advanced Melanoma by Intra-Tumoral Injections of Autologous, Purified Dendritic Cells Transduced with Gene Construct of Interleukin-12, with Dose-Dependent Expression Under the Control of an Oral Activator Ligand.
A Novel Therapeutic Strategy for Pancreatic Neoplasia Using a Novel RNAi Platform Targeting PDX-1.
Overview of the Development of Personalized Genomic Medicine and Surgery. World Journal of Surgery 2011 Aug; 35(8):1693-1699.
Final results of phase I trial of GMCSF gene-TGFß2 antisense gene autologous tumor cell (TAG) vaccine in advanced cancer.
Translational phase I study in advanced cancer patients of dual-function autologous (FANG) vaccine incorporating bifunctional shRNAfurin and GMCSF transgene expression.
Vorhies JS, Rao DD, Senzer N, Nemunaitis J: siRNA Versus shRNA for Personalized Cancer Therapy: Mechanisms and Applications (Chapter 4). In: Gene-Based Therapies for Cancer.
Systemic Administration of Bifunctional shRNA Lipoplex Targeting PDX-1 for Murine Model of Insulinoma and Pancreatic Cancer.
The Application of “Bi-functional” Short Hairpin RNA in A Furin-shRNA and GM-CSF (FANG) Autologous Vaccine for Cancer Therapy.
Tumor Suppressor Gene Therapy (Chapter 5). In: Gene-Based Therapies for Cancer. Springer Science+Business Media, LLC;
A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors. Molecular Therapy 2010 Feb; 18(2):429-434.